期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
胸壁结核术后残腔内放置负压流管与传统引流加压包扎的对照研究 被引量:1
1
作者 拜都如拉·艾尼吐 凯撒尔·吾甫尔 车勇 《新疆医学》 2021年第9期1019-1021,共3页
目的探讨胸壁结核术后残腔内放置负压引流管与传统"橡皮条"引流+加压包扎的对照研究。方法选取100例新疆医科大学第八附属医院胸外科在2015年1月~2020年1月间收治的胸壁结核患者,随机均分对照组和实验组,每组各50例,对照组患... 目的探讨胸壁结核术后残腔内放置负压引流管与传统"橡皮条"引流+加压包扎的对照研究。方法选取100例新疆医科大学第八附属医院胸外科在2015年1月~2020年1月间收治的胸壁结核患者,随机均分对照组和实验组,每组各50例,对照组患者采取传统引流+加压包扎,实验组患者术后残腔内放置负压引流管,比较两组患者术后并发症发生率、切口愈合时间、术后随访复发率。结果实验组患者术后发生残腔积液2例,无切口感染,术后并发症发生率为4.00%,对照组患者术后发生切口感染1例,残腔积液3例,手术后并发症发生率8%,两组数据对比,组间差异性显著(χ^(2)=0.005,P<0.05);两组患者手术后伤口痊愈用时对比不存在差异性(P>0.05),手术后随访时间,最长为3年,最短为1年,中位随访时间为(1.41±0.72)年。随访发现,对照组和实验组复发患者数分别有7例和1例,复发率分别为14%和2%,复发率组间差异达到显著水平(P<0.05)。结论进行胸壁结核手术后,在残腔内放置负压引流装置,患者的并发率有显著降低,同时满意度有所提升,因此值得临床进一步推广。 展开更多
关键词 胸壁结核 负压引流管 预后
下载PDF
Primary myelofibrosis with thrombophilia as first symptom combined with thalassemia and Gilbert syndrome:A case report
2
作者 Guzailinuer wufuer kaisaer wufuer +5 位作者 Tu Ba Tao Cui Ling Tao Ling Fu Ming Mao Ming-Hui Duan 《World Journal of Clinical Cases》 SCIE 2022年第13期4161-4170,共10页
BACKGROUND A 46-year-old Han man first had sigmoid sinus and transverse sinus venous thrombosis at the age of 42.At the age of 44,he once again developed thrombosis.Genetic testing showed heterozygous SERPINC1 mutatio... BACKGROUND A 46-year-old Han man first had sigmoid sinus and transverse sinus venous thrombosis at the age of 42.At the age of 44,he once again developed thrombosis.Genetic testing showed heterozygous SERPINC1 mutation,bone marrow biopsy showed fibrosis grade 1(MF-1),and JAK2 V617F mutation was positive,accompanied by UGT1A1 mutation andβ-thalassemia gene mutation.CASE SUMMARY A 46-year-old Han man was first found to have sigmoid sinus and transverse sinus venous thrombosis at the age of 42 but had no individual or family thrombosis history,and he had been regularly taking warfarin anticoagulant therapy for a long period of time.At the age of 44,venous thrombosis reappeared in parts of the intrahepatic vein,main portal vein,splenic vein,and superior mesenteric vein,and his spleen was obviously enlarged.He had a history of jaundice for many years,and genetic testing revealed that he carried a heterozygous SERPINC1 mutation.Bone marrow biopsy showed multifocal fibrous tissue hyperplasia among trabeculae and focal fibrosis.He was positive for the JAK2 V617F mutation.At the same time,UGT1A1 andβ-thalassemia gene mutations existed,and a SERPINC1 mutation and UGT1A1 mutation were both found in his parents.CONCLUSION The patient in this case had thrombophilia as the primary symptom,JAK2V617-positive myeloproliferative neoplasm(MPN)was the main potential cause,and hereditary AT-III deficiency may have been one of multiple secondary causes.It remains to be determined whether UGT1A1 andβ-thalassemia gene mutations are related to thrombophilia.However,the clinical features of MPN in this patient were hidden,and the relevant clinical features of coexisting thalassemia and hereditary Gilbert syndrome,reported here for the first time domestically and abroad,were complicating factors,causing great difficulties for a clear diagnosis.Thus,when thrombophilia has been determined,it is necessary to screen the relevant latent problems overall.When the clinical features cannot be perfectly explained by one etiology,a relevant comprehensive examination should also be initiated from the perspective of multiple etiologies. 展开更多
关键词 THROMBOPHILIA Prefibrotic myelofibrosis Negative family thrombosis history Case report
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部